Glioblastoma is a aggressive brain cancer known for its quick growth and insensitivity to typical treatments. Studies are constantly underway to identify new treatment strategies, and recently, a unique biomarker named LCA168 has emerged as a potential target for glioblastoma treatment. LCA168 is a protein that is highly expressed in GBM cells com